Review of cancer related surrogate outcomes used for PBAC decision-making


8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support registration and subsidy of new medicines. At the PBAC’s request, the Department contracted Monash University to develop a report on the use of surrogate outcome measures in PBAC submissions for cancer medicines.

The PBAC considered the report in July 2023.

Read PBS News

Michael Wonder

Posted by:

Michael Wonder